There were cheers and applause on Wednesday in Johannesburg, South Africa, where the country’s first coronavirus vaccines were administered. South Africa’s national rollout began after a complicated and disappointing start. The country received over a million units of the AstraZeneca vaccine at the beginning of February. But then new research showed that the AstraZeneca shot has limited efficacy against the predominant coronavirus variant in South Africa.
The article you just read is free because dedicated readers and listeners like you chose to support our nonprofit newsroom. Our team works tirelessly to ensure you hear the latest in international, human-centered reporting every weekday. But our work would not be possible without you. We need your help.
Make a gift today to help us reach our $25,000 goal and keep The World going strong. Every gift will get us one step closer.